✦ LIBER ✦

1331 Identifying the primary site using gene expression profiling in patients with carcinoma of an unknown primary (CUP): a feasibility study from the GEFCAPI

✍ Scribed by M. Gross-Goupil; Y. Loriot; T. Lesimple; Y. Merrouche; E. Blot; C. Massard; M.C. Mathieu; K. Fizazi

Book ID: 119600265
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(09)70504-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular Gene Expression Profiling to P

Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute

✍ Hainsworth, J. D.; Rubin, M. S.; Spigel, D. R.; Boccia, R. V.; Raby, S.; Quinn, 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 154 KB

Patient preference for either the EORTC

Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP)

✍ C. Rodary; V. Pezet-Langevin; S. Garcia-Acosta; T. Lesimple; A. Lortholary; M.C. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Evidence-based oncology mitomycin C prov

Evidence-based oncology mitomycin C provides little additional benefit in the treatment of carcinoma of unknown primary site: Abstracted from: Assersohn L, Norman AR, Cunningham D et al. A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary. European Journal of Cancer 2003; 39: 1121–1128

✍ Jonathan E Dowell 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 65 KB